Despite the increase in the amount of 340B program drug discounts, those only amounted to 3.1% of global and 7% [...] …
Category: Providers
The Health Resources and Services Administration (HRSA) has asked a federal court to dismiss a lawsuit from forty-four health systems [...] …
A federal appeals court today upheld an Arkansas law that prohibits drug manufacturer 340B contract pharmacy restrictions in the state. [...] …
Drugmaker Genentech has given some 340B hospitals advance notice of its plan to implement contract pharmacy restrictions. The biotech giant, [...] …
Two powerful Minnesota state lawmakers have introduced companion bills to expand the state’s existing 340B provider reporting requirements and add [...] …
Influential Rhode Island state lawmakers this week introduced companion bills to prohibit drugmaker 340B contract pharmacy restrictions and bar certain [...] …
Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...] …
Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...] …
The Centers for Medicare & Medicaid Services (CMS) will direct Medicare administrative contractors (MACs) to provide some accelerated payments to [...] …
Key committees in the Mississippi state house and senate last week approved companion bills that would prohibit drugmaker 340B contract [...] …